Vaughan David Investments LLC Amgen Inc Transaction History

Vaughan David Investments LLC

$4.35 Billion
Q3 2024

A detailed history of Vaughan David Investments LLC transactions in Amgen Inc stock. As of the latest transaction made, Vaughan David Investments LLC holds 175,680 shares of AMGN stock, worth $45.9 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares

175,680

Previous 175,610 0.04%

Holding current value

$45.9 Million

Previous $54.9 Million 3.17%

% of portfolio

1.3%

Previous 1.39%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$309.38 - $337.38 $21,656 - $23,616	70 Added 0.04%	175,680 $56.6 Million
Q2 2024 Aug 07, 2024	BUY	$262.75 - $319.31 $118,237 - $143,689	450 Added 0.26%	175,610 $54.9 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $65,873 - $79,517	-245 Reduced 0.14%	175,160 $49.8 Million
Q4 2023 Jan 29, 2024	BUY	$255.7 - $288.46 $15,853 - $17,884	62 Added 0.04%	175,405 $50.5 Million
Q3 2023 Nov 07, 2023	BUY	$218.65 - $271.46 $287,962 - $357,512	1,317 Added 0.76%	175,343 $47.1 Million
Q2 2023 Aug 02, 2023	BUY	$214.27 - $253.37 $192,414 - $227,526	898 Added 0.52%	174,026 $38.6 Million
Q1 2023 May 02, 2023	SELL	$225.79 - $275.2 $142,021 - $173,100	-629 Reduced 0.36%	173,128 $41.9 Million
Q4 2022 Feb 07, 2023	SELL	$229.03 - $291.01 $308,274 - $391,699	-1,346 Reduced 0.77%	173,757 $45.6 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $205,380 - $231,632	915 Added 0.53%	175,103 $39.5 Million
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $173,032 - $192,555	750 Added 0.43%	174,188 $42.4 Million
Q1 2022 May 09, 2022	BUY	$219.27 - $242.57 $317,283 - $350,998	1,447 Added 0.84%	173,438 $41.9 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $203,255 - $232,607	1,022 Added 0.6%	171,991 $38.7 Million
Q3 2021 Nov 04, 2021	SELL	$212.27 - $248.7 $53,067 - $62,175	-250 Reduced 0.15%	170,969 $36.4 Million
Q2 2021 Aug 11, 2021	BUY	$233.58 - $259.14 $462,721 - $513,356	1,981 Added 1.17%	171,219 $41.7 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $183,741 - $214,120	-828 Reduced 0.49%	169,238 $42.1 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $192,794 - $229,583	891 Added 0.53%	170,066 $39.1 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $128,353 - $142,739	-547 Reduced 0.32%	169,175 $43 Million
Q2 2020 Aug 07, 2020	BUY	$197.81 - $242.74 $201,766 - $247,594	1,020 Added 0.6%	169,722 $40 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $687,044 - $911,209	-3,770 Reduced 2.19%	168,702 $34.2 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $168,018 - $215,961	-888 Reduced 0.51%	172,472 $41.6 Million
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $272,830 - $326,907	1,567 Added 0.91%	173,360 $33.5 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $577,448 - $676,900	3,464 Added 2.06%	171,793 $31.7 Million
Q1 2019 May 08, 2019	BUY	$180.87 - $203.88 $300,786 - $339,052	1,663 Added 1.0%	168,329 $32 Million
Q4 2018 Feb 08, 2019	SELL	$178.4 - $208.25 $342,884 - $400,256	-1,922 Reduced 1.14%	166,666 $32.4 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $51,325 - $57,862	-277 Reduced 0.16%	168,588 $34.9 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $694,587 - $780,171	-4,183 Reduced 2.42%	168,865 $31.2 Million
Q1 2018 May 04, 2018	BUY	$169.43 - $198.0 $270,918 - $316,602	1,599 Added 0.93%	173,048 $29.5 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $412,691 - $461,102	2,445 Added 1.45%	171,449 $29.8 Million
Q3 2017 Nov 08, 2017	SELL	$167.29 - $191.0 $274,522 - $313,431	-1,641 Reduced 0.96%	169,004 $31.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	170,645	170,645 $29.4 Million

Others Institutions Holding AMGN

# of Institutions

3,126

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vaughan David Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vaughan David Investments LLC with notifications on news.

Account

Vaughan David Investments LLC Amgen Inc Transaction History